(Q44356545)

2 December 2017

title

A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells (English)

1 reference

2 December 2017

0 references

Erin R Steenblock

1

1 reference

2 December 2017

Tarek M Fahmy

series ordinal

2

1 reference

2 December 2017

publication date

4 March 2008

1 reference

2 December 2017

1 reference

2 December 2017

volume

16

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

765-772

1 reference

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Control of autoimmunity by naturally arising regulatory CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Adoptive-cell-transfer therapy for the treatment of patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

T-cell therapy of leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

The ABCs of artificial antigen presentation

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Efficient presentation of naturally processed HLA class I peptides by artificial antigen-presenting cells for the generation of effective antitumor responses

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Dual function of Drosophila cells as APCs for naive CD8+ T cells: implications for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide-class I complexes and recombinant B7-Fc proteins

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Absorbable microparticulate cation exchanger for immunotherapeutic delivery

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Liposomes with incorporated MHC class II/peptide complexes as antigen presenting vesicles for specific T cell activation

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Artificial antigen-presenting cells as a tool to exploit the immune 'synapse'.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Exosomes: composition, biogenesis and function

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Spinning molecular immunology into successful immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Cytokine control of memory T-cell development and survival

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Engineering antitumor immunity by T-cell adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Polymers for the sustained release of proteins and other macromolecules

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Transplantation of brain cells assembled around a programmable synthetic microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

T cell receptor antagonist peptides induce positive selection

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

T-cell activation by soluble MHC oligomers can be described by a two-parameter binding model

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

B7-1-dependent co-stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Protein instability in poly(lactic-co-glycolic acid) microparticles.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

T cells coactivated with immobilized anti-CD3 and anti-CD28 as potential immunotherapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Artificial antigen-presenting cells: artificial solutions for real diseases

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Mechanisms of polymer degradation and erosion

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Competition for cytokines: T(reg) cells take all

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.11

7 January 2021

Identifiers

DOI

10.1038/MT.2008.11

1 reference

2 December 2017

1 reference